Contribution: Industrial Research Assistance Program – Contributions to Firms
PBG BioPharma Inc.
$237,810.00
Formulation, scale up and mechanism of action of a potential broad spectrum anti-viral plant isolate PBG-007
FY 2020-21 · 2021-02-01
Summary
This project aims to develop broad spectrum immuno-modulatory Natural Health Product to fight virus infections including COVID-19.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Leduc|Leduc, Alberta, Canada
Recipient Type
For-profit organization
Business Number
720710318
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-02-01 | 2020-21 | $220,000.00 |
| 1 | 2021-02-01 | 2020-21 | $220,000.00 |
| 2 | 2021-02-01 | 2020-21 | $220,000.00 |
| 3 | 2021-02-01 | 2020-21 | $237,810.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 17,810 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 17 810 dollars.
Agreement End Date
2023-02-28
Agreement Number
968451
Agreement Start Date
2021-02-01
Agreement Title
Formulation, scale up and mechanism of action of a potential broad spectrum anti-viral plant isolate PBG-007
Agreement Title (French)
Formulation, mise à l'échelle et mécanisme d'action d'un isolat végétal antiviral potentiel à large spectre PBG-007
Agreement Type
Contribution
Agreement Value
$237,810.00
Amendment Date
2023-01-13
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project aims to develop broad spectrum immuno-modulatory Natural Health Product to fight virus infections including COVID-19.
Description (French)
Ce projet vise à mettre au point un produit de santé naturel immuno-modulateur à large spectre pour lutter contre les infections virales, notamment la COVID-19.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton--Wetaskiwin
Federal Riding (French)
Edmonton--Wetaskiwin
Federal Riding Number
48021
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
720710318
Recipient City
Leduc|Leduc
Recipient Country
CA
Recipient Legal Name
PBG BioPharma Inc.
Recipient Operating Name
PBG BioPharma
Recipient Postal Code
T9E 0Z4
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2020-2021-Q4-968451
